新氟喹诺酮类抗菌药—Sitafloxacin的体外抗菌活性
出处
《华西医学》
CAS
2001年第1期122-124,共3页
West China Medical Journal
参考文献10
-
1Kitamura A,Hoshino K,Kimura Y,et al.Contribution of the C-8 substituent of DU6859a, a new potent fluoroquinolone, to its activity against DNA Gyrase mutants of pseudomonas aeruginosa[].Antimicrobial Agents and Chemotherapy.1995
-
2Thomson K,Sanders CC.The effects of increasing Ievels of quinolone resistance on invitro activity of four quinolones[].Journal of Antimicrobial Chemotherapy.1998
-
3Sato K,Hoshino K,Tanaka M,et al.Antimirobial activity of DU-6859a, a new potent fluoroquinolone, against clinical isolates[].Antimicrobial Agents and Chemotherapy.1992
-
4Nakane T,Iyobe S,Sato K,et al.In vitro antibacterial activity of DU-6859a, a new fluroquinolone[].Antimicrobial Agents and Chemotherapy.1995
-
5Akasaka T,Kurosaka S,Uchida Y,et al.Antibacterial activities and inhibitory effects of Sitafloxacin (DU-6859a) and its optical isomers against type topoisomerases[].Antimicrobial Agents and Chemotherapy.1998
-
6Tanaka M,Onodera Y,Uchida Y,et al.Inhibitory activities of quinolones against DNA Gyrase and Topoisomerase Ⅳpurified from staphylococcus aureur[].Antimicrobial Agents and Chemotherapy.1997
-
7Wang T,Tanaka M,Sato K.Detection of grlA and gyrA mutations in 334 staphylococcus aureus strains[].Antimicrobial Agents and Chemotherapy.1998
-
8Masshall SA,Jones RN,Murray PR,et al.In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates[].Journal of Antimicrobial Chemotherapy.1993
-
9Deguchi T,Yasuda M,Nakano M,et al.Antimicrobial activity of a new fluoroquinolone DU-6859a, against quinolone-resistant clinical isolates of Neisseria gonorrhoeae with genetic alterations in the gyrA subunit of DNA gyrase and the parC subunit of topoisomeraseⅣ[].Journal of Antimicrobial Chemotherapy.1997
-
10Visalli MA,Jacobs MR,Appelbaum PC.MIC and time-kill study of activities of DU-6859a,Ciprofloxacin, Levofloxacin, Sparfloxacin, Cefotaxime, Imipenem, and Vancomycin against nine penicllin-susceptical and Resistant pneumcocci[].Antimicrobial Agents and Chemotherapy.1996
-
1雷妮,高嵩,陈卫东,查大俊,陈延杰,张劲,吴勇.西他沙星的药理和临床评价[J].中国临床研究,2010,23(10):930-932. 被引量：2
-
2邹启园,陈林,蒋玉富.耐氟喹诺酮类大肠杆菌所致肾盂肾炎一例[J].中华内科杂志,1994,33(11):779-779.
-
3黄胜炎（摘）.国外新批准上市的药物新制剂新剂型（126）[J].中国制药信息,2008,24(6):8-10. 被引量：2
-
4日本批准西他沙星水合物片剂和细粒剂上市[J].世界临床药物,2008,29(4):195-195.
-
5景新（摘）.西他沙星在日本上市[J].国外药讯,2008(8):28-28.
-
6陈国彬,岳利剑.合成西他沙星的研究进展[J].合成化学,2012,20(1):7-12. 被引量：8
-
7高亚萍,黑研,纪星涉,杨南林,刘玉,沈倍奋,杨光.西他沙星对小鼠模型耐甲氧西林金黄色葡萄球菌肺炎保护作用的研究[J].抗感染药学,2015,12(3):339-342. 被引量：1
-
8马培奇.国外新近批准主要新药（二十五）[J].中国制药信息,2008,24(11):11-19. 被引量：2
-
9竺伟,陈欢生,胡永安.奈韦拉平的合成[J].中国医药工业杂志,2012,43(6):411-413. 被引量：3
-
10环丙胺开发前景看好[J].中国药业,1998,7(12):18-18.
